Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 1/20 | 0.49 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.49 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.49 |
| ▸ | GSR | P00390 | 1/20 | 0.47 |
| ▸ | DPP7 | Q9UHL4 | 4/20 | 0.46 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.46 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.46 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.44 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | TLR2 | O60603 | 2/20 | 0.39 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.38 |
| ▸ | RRM1 | P23921 | 1/20 | 0.37 |
| ▸ | TERT | O14746 | 3/20 | 0.36 |
| ▸ | LTA4H | P09960 | 1/20 | 0.36 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.35 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.35 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6563762 | 0.95 | SLC15A1 (0.45) | GNAI3GNAO1GNAI1GSRDPP7 | |
| SCHEMBL10062328 | 0.83 | GNAI3 (0.64) | GNAI3GNAO1GNAI1GSRDPP7 | |
| SCHEMBL7294153 | 0.82 | GNAI3 (0.54) | GNAI3GNAO1GNAI1GSRDPP7 | |
| SCHEMBL5499007 | 0.82 | GSR (0.61) | GNAI3GNAO1GNAI1GSRDPP7 | |
| SCHEMBL29989156 | 0.81 | GSR (0.57) | GNAI3GNAO1GNAI1GSRDPP7 | |
| SCHEMBL5495401 | 0.80 | GSR (0.59) | GNAI3GNAO1GNAI1GSRDPP7 | |
| SCHEMBL4414228 | 0.78 | DPP4 (0.49) | GSRDPP8DPP9SLC15A1DPP4 | |
| SCHEMBL2969796 | 0.78 | DPP4 (0.49) | GSRDPP7DPP8DPP9SLC15A1 | |
| SCHEMBL28122346 | 0.78 | GSR (0.44) | GNAI3GNAO1GNAI1GSRDPP7 | |
| SCHEMBL29616781 | 0.77 | SLC15A1 (0.50) | GNAI3GNAO1GNAI1GSRDPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240408027-A1 | HIGH DRUG LOADING POLYMERS | VANDERBILT UNIVERSITY | 2024-12-12 | — | — | US | claimed |
| US-11912894-B2 | Antimicrobial and antifouling conformal hydrogel coatings | CORNELL UNIVERSITY (US) | 2024-02-27 | — | — | US | claimed |
| US-11655343-B2 | Alginate hydrogel compositions | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-05-23 | — | — | US | claimed |
| WO-2023076220-A1 | CONJUGATES HAVING ANTIFOULING NANOPARTICLES AND METHODS OF USE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-05-04 | — | — | WO | claimed |
| WO-2023059833-A1 | HIGH DRUG LOADING POLYMERS | VANDERBILT UNIVERSITY (US) | 2023-04-13 | — | — | WO | claimed |
| US-20200172741-A1 | ANTIMICROBIAL AND ANTIFOULING CONFORMAL HYDROGEL COATINGS | CORNELL UNIVERSITY | 2020-06-04 | — | — | US | claimed |
| US-20150274891-A1 | MEMBRANES WITH IMPROVED FLUX AND METHOD FOR THEIR PREPARATION | BASF SE (DE) | 2015-10-01 | — | — | US | claimed |
| US-12338330-B2 | Alginate hydrogel compositions | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2025-06-24 | — | — | US | disclosed |
| WO-2025129139-A1 | TRIBLOCK COPOLYMERS AND HYDROGELS THEREOF | VANDERBILT UNIVERSITY (US) | 2025-06-19 | — | — | WO | disclosed |
| US-20240408027-A1 | HIGH DRUG LOADING POLYMERS | VANDERBILT UNIVERSITY | 2024-12-12 | — | — | US | disclosed |
| US-11912894-B2 | Antimicrobial and antifouling conformal hydrogel coatings | CORNELL UNIVERSITY (US) | 2024-02-27 | — | — | US | disclosed |
| US-20230348675-A1 | ALGINATE HYDROGEL COMPOSITIONS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-11-02 | — | — | US | disclosed |
| US-11655343-B2 | Alginate hydrogel compositions | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-05-23 | — | — | US | disclosed |
| WO-2014095754-A1 | FILTRATION SYSTEMS AND MEMBRANES WITH ENHANCED FLUX AND METHOD FOR THEIR PREPARATION | BASF SE (DE) | 2014-06-26 | — | — | WO | disclosed |
| WO-2014095753-A1 | MEMBRANES WITH IMPROVED FLUX AND METHOD FOR THEIR PREPARATION | BASF SE (DE) | 2014-06-26 | — | — | WO | disclosed |
| WO-2014095749-A1 | FILTRATION SYSTEMS AND MEMBRANES WITH ENHANCED FLUX AND METHOD FOR THEIR PREPARATION | BASF SE (DE) | 2014-06-26 | — | — | WO | disclosed |
| EP-1156031-B1 | NOVEL COMPOUND, POLYMER PREPARED FROM THE COMPOUND, AND COMPOSITION COMPRISING THE POLYMER | POLA CHEM IND INC (JP) | 2008-09-17 | — | — | EP | disclosed |
| JP-2004137382-A | WATER-ABSORBING COMPOSITION | EHIME PREFECTURE | 2004-05-13 | — | — | JP | disclosed |
| US-6703468-B1 | COMPOSITION FOR TOPICAL ADMINISTRATION TO SKIN OR HAIR COMPRISING SUITABLE CARRIER AND EFFECTIVE AMOUNT OF SPECIFIED POLYMER WHICH HAS BENEFICIAL EFFECTS ON SKIN FUNCTIONS | POLA CHEMICAL INDUSTRIES INC. (JP) | 2004-03-09 | — | — | US | disclosed |
| EP-1156031-A1 | NOVEL COMPOUND, POLYMER PREPARED FROM THE COMPOUND, AND COMPOSITION COMPRISING THE POLYMER | POLA CHEMICAL INDUSTRIES, INC. (JP) | 2001-11-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240408027-A1 | HIGH DRUG LOADING POLYMERS | ABCB1, ABCB11, FCGR2A | GNAI3 3977/4885GNAO1 3553/4885GNAI1 3697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.